Back to the newspaper
DEVELOPING · Attributed source report · science · World

Trial results posted: Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

NULLPEN · Source published 11/16/2026, 12:00:00 AM UTC

ClinicalTrials.gov records the first posting of results for study NCT03534453 on 2026-11-16. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

The source record

National Library of Medicine, National Institutes of Health

Source: ClinicalTrials.gov, National Library of Medicine, United States. Registry entries are filed by trial sponsors; the registry does not verify them.Retrieved 2026-11-16T15:30:33.126Z. Updated on NULLPEN 2026-11-16T15:30:35.971Z.Revision sha256:abe98f2bcf25a9a8f2b83d5c01ecded22edf83895b6109aabd87654981e677a8